Dr. Ghulam Qureshi, M.D

NPI: 1245201045
Total Payments
$7,032
2023 Payments
$81.90
Companies
37
Transactions
170
Medicare Patients
442
Medicare Billing
$84,241

Payment Breakdown by Category

Food & Beverage$6,803 (96.7%)
Education$228.64 (3.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,803 161 96.7%
Education $228.64 9 3.3%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $906.66 21 $0 (2019)
Novartis Pharmaceuticals Corporation $729.78 21 $0 (2020)
AstraZeneca Pharmaceuticals LP $677.98 11 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $497.90 5 $0 (2019)
Janssen Biotech, Inc. $477.73 10 $0 (2020)
Celgene Corporation $444.88 7 $0 (2019)
E.R. Squibb & Sons, L.L.C. $370.98 11 $0 (2019)
Alexion Pharmaceuticals, Inc. $362.17 4 $0 (2019)
PFIZER INC. $343.68 11 $0 (2019)
Pharmacyclics LLC, An AbbVie Company $244.24 4 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $81.90 1 AstraZeneca Pharmaceuticals LP ($81.90)
2020 $326.66 5 AstraZeneca Pharmaceuticals LP ($189.39)
2019 $1,955 22 Novartis Pharmaceuticals Corporation ($252.36)
2018 $1,536 29 AstraZeneca Pharmaceuticals LP ($289.93)
2017 $3,133 113 Genentech USA, Inc. ($775.41)

All Payment Transactions

170 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
07/11/2023 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $81.90 General
Category: Oncology
03/05/2020 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $35.33 General
Category: Oncology
02/25/2020 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $81.60 General
Category: Oncology
02/07/2020 Novartis Pharmaceuticals Corporation ADAKVEO (Biological) Food and Beverage In-kind items and services $101.94 General
Category: HEMATOLOGY
02/05/2020 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $105.67 General
01/09/2020 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $2.12 General
12/08/2019 Dova Pharmaceuticals Doptelet (Drug) Food and Beverage In-kind items and services $118.81 General
Category: Hepatology
12/07/2019 Dova Pharmaceuticals Doptelet (Drug) Food and Beverage In-kind items and services $122.15 General
Category: Hepatology
10/16/2019 Medtronic USA, Inc. OSTEOCOOL RF ABLATION (Device) Food and Beverage In-kind items and services $102.40 General
Category: Neuro Pain (includes Interventional)
10/10/2019 Takeda Pharmaceuticals U.S.A., Inc. NINLARO (Drug) Food and Beverage In-kind items and services $124.90 General
Category: Oncology
08/21/2019 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Food and Beverage In-kind items and services $116.04 General
Category: ONCOLOGY
08/05/2019 Genentech USA, Inc. Rituxan (Biological), GAZYVA, VENCLEXTA Food and Beverage In-kind items and services $131.25 General
Category: BioOncology/Immunology
06/26/2019 Novartis Pharmaceuticals Corporation RYDAPT (Drug) Food and Beverage In-kind items and services $120.85 General
Category: HEMATOLOGY
06/12/2019 Astellas Pharma US Inc XTANDI (Drug) Food and Beverage In-kind items and services $117.04 General
Category: ONCOLOGY
06/10/2019 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $118.78 General
05/21/2019 PFIZER INC. MYLOTARG (Biological), BOSULIF, BESPONSA Food and Beverage In-kind items and services $10.88 General
Category: ONCOLOGY
05/16/2019 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Food and Beverage In-kind items and services $15.47 General
Category: ONCOLOGY
05/14/2019 Seattle Genetics, Inc. ADCETRIS (Biological) Education In-kind items and services $12.29 General
Category: Oncology
05/09/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $104.02 General
Category: ONCOLOGY
05/09/2019 Puma Biotechnology, Inc. Nerlynx (Drug) Food and Beverage In-kind items and services $15.76 General
Category: Oncology
04/30/2019 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $86.89 General
Category: Oncology
04/18/2019 Celgene Corporation Abraxane (Drug) Food and Beverage In-kind items and services $113.95 General
Category: Oncology
04/10/2019 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $112.09 General
Category: ONC
04/08/2019 Seattle Genetics, Inc. ADCETRIS (Biological) Education In-kind items and services $12.29 General
Category: Oncology
03/27/2019 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $117.17 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 11 442 2,255 $222,645 $84,241
Total Patients
442
Total Services
2,255
Medicare Billing
$84,241
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 238 669 $133,800 $50,542 37.8%
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units Office 2020 19 1,310 $36,680 $9,444 25.7%
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a Office 2020 11 59 $9,440 $9,360 99.2%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2020 33 38 $15,010 $4,336 28.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 20 21 $8,400 $3,447 41.0%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 14 14 $5,460 $2,182 40.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 16 35 $4,725 $2,047 43.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 18 18 $2,700 $1,087 40.3%
96365 Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Office 2020 15 16 $2,400 $924.96 38.5%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 43 56 $3,080 $618.21 20.1%
96375 Injection of different drug or substance into a vein for therapy, diagnosis, or prevention Office 2020 15 19 $950.00 $252.92 26.6%

About Dr. Ghulam Qureshi, M.D

Dr. Ghulam Qureshi, M.D is a Hematology & Oncology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245201045.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ghulam Qureshi, M.D has received a total of $7,032 in payments from pharmaceutical and medical device companies, with $81.90 received in 2023. These payments were reported across 170 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,803).

As a Medicare-enrolled provider, Qureshi has provided services to 442 Medicare beneficiaries, totaling 2,255 services with total Medicare billing of $84,241. Data is available for 1 year (2020–2020), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Other Specialties Specialist
  • Location Richmond, VA
  • Active Since 01/30/2006
  • Last Updated 09/25/2020
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1245201045

Products in Payments

  • NINLARO (Drug) $492.73
  • IMBRUVICA (Drug) $436.12
  • Avastin (Biological) $293.30
  • Imbruvica (Drug) $244.24
  • SOLIRIS (Drug) $243.39
  • IMFINZI (Drug) $241.36
  • Doptelet (Drug) $240.96
  • KEYTRUDA (Biological) $235.70
  • TAGRISSO (Drug) $223.60
  • RYDAPT (Drug) $209.94
  • Yescarta (Drug) $204.83
  • Rituxan (Biological) $192.59
  • PROMACTA (Drug) $190.23
  • INJECTAFER (Drug) $175.99
  • OPDIVO (Biological) $161.62
  • Revlimid (Drug) $158.88
  • XTANDI (Drug) $158.10
  • Abraxane (Drug) $138.74
  • TECENTRIQ (Biological) $121.91
  • TASIGNA (Drug) $121.77

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Richmond